MARKET

ALZN

ALZN

Alzamend Neuro Inc
NASDAQ
2.160
+0.010
+0.47%
Closed 17:01 12/18 EST
OPEN
2.150
PREV CLOSE
2.150
HIGH
2.270
LOW
2.144
VOLUME
52.59K
TURNOVER
0
52 WEEK HIGH
12.06
52 WEEK LOW
1.880
MARKET CAP
8.21M
P/E (TTM)
-0.3785
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ALZN last week (1208-1212)?
Weekly Report · 4d ago
Alzamend Neuro Q2 EPS $(0.30) Beats $(1.96) Estimate
Benzinga · 12/09 22:37
Weekly Report: what happened at ALZN last week (1201-1205)?
Weekly Report · 12/08 10:02
Weekly Report: what happened at ALZN last week (1124-1128)?
Weekly Report · 12/01 09:58
Weekly Report: what happened at ALZN last week (1117-1121)?
Weekly Report · 11/24 10:02
EMBC Q4 Preview: Product Momentum and Strategy Gains to Support Growth?
NASDAQ · 11/20 12:50
BUZZ-U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet
Reuters · 11/19 18:59
BUZZ-Alzamend rises after completing mid-stage brain lithium study
Reuters · 11/19 13:34
More
About ALZN
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). The Company's pipeline consists of two novel therapeutic drug candidates: AL001, and ALZN002. AL001 is a patented ionic cocrystal technology delivering a therapeutic combination of lithium, salicylate and L-proline through three royalty-bearing exclusive worldwide licenses from the University of South Florida Research Foundation, Inc., (the Licensor). AL001 is used for Alzheimer's, BD, MDD and PTSD treatment. ALZN002 is a patented method using a mutant peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer's by removing beta-amyloid from the brain through a royalty-bearing exclusive worldwide license from the Licensor.

Webull offers Alzamend Neuro Inc stock information, including NASDAQ: ALZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALZN stock methods without spending real money on the virtual paper trading platform.